11.06.25 -- Pfizer Strengthens Obesity Foothold With Metsera Acquisition

Traditional drug models fail to predict performance in human skin. Advanced, multifactorial ex vivo disease models directly address infection to significantly de-risk formulation development.

Streamlining development through an integrated CDMO can reduce risk and improve quality. Discover why specialized expertise in linker chemistry is key to overcoming the complexity of ADC manufacturing.

Sterile manufacturing relies on three main contamination control strategies: cleanrooms, RABS, and isolators. Understand how each system compares in sterility assurance and operational flexibility.

Discover the critical process considerations and custom engineering required to handle temperature-sensitive and high-viscosity pharmaceutical materials.

Learn how outcome-based automation helps life sciences manufacturers reduce risk, improve performance, and drive measurable results—by aligning tools with business goals.

Outlined here are the benefits of PFS and how they relate to the delivery of drugs, how SARS-CoV-2 could be fueling an explosive increase in PFS demand, and how partnering with a CDMO is the key.

The Requirements Traceability Matrix ensures every system requirement is verified through testing, supporting compliance, reducing risk, and strengthening validation efforts across development.

Gain valuable insights into the jet milling process and Quality by Design approach for inhalation drug delivery and their potential applications in drug development.

Explore how to minimize tablet defects like picking, sticking, and capping, as well as common issues and the critical role of blending in achieving quality tablets.

Watch to find out more about new data on nanotechnology formulations for multiple dose forms and routes of delivery, including oral, long-acting injectables, inhalation, and ophthalmic.

See how automated sample prep for immunosuppressant drug analysis improves accuracy, reduces contamination, and streamlines LC-MS/MS workflows.

Uncover a company that tripled productivity and cut costs by optimizing its seed train process to achieve major gains without infrastructure expansion.

Struggling with data integrity challenges? Discover proven strategies for GxP compliance and inspection readiness in this essential webinar. Learn to build a robust framework and avoid common pitfalls.

Precision powder microdosing makes it possible to quickly get formulations to the clinic, saving time, money, and use of limited APIs.

Examine the advantages of 2000 and 3000 L single-use mixing systems and experimental results demonstrating their capacity to deliver high power at large scales and flexibility for use at lower volumes.

GLP-1 receptor agonists are revolutionizing therapeutics beyond diabetes. Review analytical innovations that ensure safety and efficacy as these peptides expand into multiple treatments.

John McDermott, VP of Scientific Consulting, shares insights on the benefits of evaluating targeted oncology molecules in healthy volunteers and applying an effective platform to accelerate optimization.

Discover how ODT compares against standard oral tablets, how the same molecule can produce a different outcome when utilizing ODT, and the findings from over 20 published studies.

Learn how we were able to provide seamless technology transfers and uninterrupted production to deliver critical therapies efficiently and reliably to patients.